Hypoxia-regulated gene expression explains differences between melanoma cell line-derived xenografts and patient-derived xenografts

por Bhadury, Joydeep, Einarsdottir, Berglind O., Podraza, Agnieszka, Bagge, Roger Olofsson, Stierner, Ulrika, Ny, Lars, López, Marcela Dávila, Nilsson, Jonas A.
Publicado 2016

Hip Fractures and Bone Mineral Density in the Elderly—Importance of Serum 25-Hydroxyvitamin D

por Steingrimsdottir, Laufey, Halldorsson, Thorhallur I., Siggeirsdottir, Kristin, Cotch, Mary Frances, Einarsdottir, Berglind O., Eiriksdottir, Gudny, Sigurdsson, Sigurdur, Launer, Lenore J., Harris, Tamara B., Gudnason, Vilmundur, Sigurdsson, Gunnar
Publicado 2014

Melanoma patient-derived xenografts accurately model the disease and develop fast enough to guide treatment decisions

por Einarsdottir, Berglind O., Bagge, Roger Olofsson, Bhadury, Joydeep, Jespersen, Henrik, Mattsson, Jan, Nilsson, Lisa M., Truvé, Katarina, López, Marcela Dávila, Naredi, Peter, Nilsson, Ola, Stierner, Ulrika, Ny, Lars, Nilsson, Jonas A.
Publicado 2014

High expression of ZNF703 independent of amplification indicates worse prognosis in patients with luminal B breast cancer

por Reynisdottir, Inga, Arason, Adalgeir, Einarsdottir, Berglind O, Gunnarsson, Haukur, Staaf, Johan, Vallon-Christersson, Johan, Jonsson, Goran, Ringnér, Markus, Agnarsson, Bjarni A, Olafsdottir, Kristrun, Fagerholm, Rainer, Einarsdottir, Thorbjorg, Johannesdottir, Gudrun, Johannsson, Oskar Thor, Nevanlinna, Heli, Borg, Ake, Barkardottir, Rosa Bjork
Publicado 2013

Mutational Signature and Transcriptomic Classification Analyses as the Decisive Diagnostic Tools for a Cancer of Unknown Primary

por Bagge, Roger Olofsson, Demir, Akif, Karlsson, Joakim, Alaei-Mahabadi, Babak, Einarsdottir, Berglind O., Jespersen, Henrik, Lindberg, Mattias F., Muth, Andreas, Nilsson, Lisa M., Persson, Marta, Svensson, Johanna B., Söderberg, Elin M.V., de Krijger, Ronald R., Nilsson, Ola, Larsson, Erik, Stenman, Göran, Nilsson, Jonas A.
Publicado 2018

A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanoma

por Einarsdottir, Berglind O., Karlsson, Joakim, Söderberg, Elin M. V., Lindberg, Mattias F., Funck-Brentano, Elisa, Jespersen, Henrik, Brynjolfsson, Siggeir F., Olofsson Bagge, Roger, Carstam, Louise, Scobie, Martin, Koolmeister, Tobias, Wallner, Olof, Stierner, Ulrika, Berglund, Ulrika Warpman, Ny, Lars, Nilsson, Lisa M., Larsson, Erik, Helleday, Thomas, Nilsson, Jonas A.
Publicado 2018

Correction: A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanoma

por Einarsdottir, Berglind O., Karlsson, Joakim, Söderberg, Elin M. V., Lindberg, Mattias F., Funck-Brentano, Elisa, Jespersen, Henrik, Brynjolfsson, Siggeir F., Bagge, Roger Olofsson, Carstam, Louise, Scobie, Martin, Koolmeister, Tobias, Wallner, Olof, Stierner, Ulrika, Berglund, Ulrika Warpman, Ny, Lars, Nilsson, Lisa M., Larsson, Erik, Helleday, Thomas, Nilsson, Jonas A.
Publicado 2020